Picture of Vyant Bio logo

VYNT — Vyant Bio News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapNeutral

Brief: Cancer Genetics Files Prospectus Related To Resale Of Upto 5.7 Million Shares Of Common Stock, Including Stock Issuable On Exercise Of Warrants - SEC Filing

Feb 1 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS FILES PROSPECTUS RELATED TO RESALE OF UPTO
5.7
MILLION SHARES OF COMMON STOCK, INCLUDING STOCK ISSUABLE ON
EXERCISE OF WARRANTS - SEC FILING
    * CANCER GENETICS SAYS RESALE OF COMMON STOCK IS BY SELLING
STOCKHOLDERS

Source text for Eikon: [https://bit.ly/39FWki9]
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Vyant Bio

See all news